Hakim‐Moulay Dehbi

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

Rasha Al‐Lamee, David Thompson, Hakim‐Moulay Dehbi et al. · The Lancet · 2017 · 975 citations · Full text

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Unit +6

Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI

Justin E. Davies, Sayan Sen, Hakim‐Moulay Dehbi et al. · New England Journal of Medicine · 2017 · 926 citations · Full text

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

Beatrice Seddon, Sandra J. Strauss, Jeremy Whelan et al. · The Lancet Oncology · 2017 · 502 citations · Full text

Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial

Hakim‐Moulay Dehbi, Ujjal K. Mallick, Jonathan Wadsley et al. · The Lancet Diabetes & Endocrinology · 2018 · 136 citations · Full text

Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease

Rasha Al‐Lamee, James P. Howard, Matthew Shun‐Shin et al. · Circulation · 2018 · 109 citations